OREGON (USA): Sovaldi, a new pill for Hepatitis-C. It cures the liver-wasting disease in nine out of 10 patients, but treatment can cost more than $90,000. Leading medical societies recommend the drug and patients are clamouring for it. But insurance companies and state Medicaid programmes are gagging on the price.